Conversely, reduced TRPV2 expression has been detected in advanced glioma, therefore its exogenous overexpression negatively affected the in vitro and in vivo proliferation of glioma cells, indicating that in different cancers, TRPV2 may function either as a tumour promoter or tumour suppressor [211]. The gene discussed is TRPV2; the disease is glioma.